nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acknowledgement to Reviewers
|
|
|
2012 |
|
4 |
p. I- 1 p. |
artikel |
2 |
Aggressive relapsing multiple sclerosis characterized by rapid disability progression
|
Scott, Thomas F. |
|
2013 |
|
4 |
p. 370-376 7 p. |
artikel |
3 |
An agent-based simulation model for informed shared decision making in multiple sclerosis
|
Veloso, Mário |
|
2013 |
|
4 |
p. 377-384 8 p. |
artikel |
4 |
A retrospective review of lithium usage in veterans with multiple sclerosis
|
Rinker II, John R. |
|
2013 |
|
4 |
p. 327-333 7 p. |
artikel |
5 |
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients
|
Basnyat, Pabitra |
|
2015 |
|
4 |
p. 334-338 5 p. |
artikel |
6 |
Association of vitamin D deficiency with RNFL thickness in MS individuals without history of optic neuritis
|
Fjeldstad, Cecilie |
|
2014 |
|
4 |
p. 489-493 5 p. |
artikel |
7 |
Can white matter changes occur in disorders of peripheral nerve hyperexcitability?
|
Sedarous, Mary |
|
2013 |
|
4 |
p. 388-390 3 p. |
artikel |
8 |
Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables
|
Vuletic, Simona |
|
2014 |
|
4 |
p. 533-541 9 p. |
artikel |
9 |
Chronic cerebrospinal venous insufficiency is unlikely to be a direct trigger of multiple sclerosis
|
Simka, Marian |
|
2013 |
|
4 |
p. 334-339 6 p. |
artikel |
10 |
Clinical decision-making in multiple sclerosis: Challenges reported internationally with emerging treatment complexity
|
Ng, Pamela |
|
2015 |
|
4 |
p. 320-328 9 p. |
artikel |
11 |
CLIPPERS syndrome: Case report in a Brazilian patient with a long term disease evolution
|
Marinho, Patricia Beatriz Christino |
|
2015 |
|
4 |
p. 311-314 4 p. |
artikel |
12 |
Cognitive impact of anticholinergic medication in MS: Adding insult to injury?
|
Cruce, Roxana |
|
2012 |
|
4 |
p. 156-161 6 p. |
artikel |
13 |
Cognitive impairment in multiple sclerosis: An 18 year follow-up study
|
Strober, Lauren B. |
|
2014 |
|
4 |
p. 473-481 9 p. |
artikel |
14 |
Cognitive performance profile in different phenotypes of MS with cognitive complaints
|
Rosti-Otajärvi, Eija |
|
2014 |
|
4 |
p. 463-472 10 p. |
artikel |
15 |
Computerized cognitive testing for patients with multiple sclerosis
|
Lapshin, Helen |
|
2012 |
|
4 |
p. 196-201 6 p. |
artikel |
16 |
Corrigendum to “Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis” [Mult. Scler. Relat. Disord. 4 (2015) 104–111]
|
Racosta, Juan Manuel |
|
2015 |
|
4 |
p. 385- 1 p. |
artikel |
17 |
Deep brain stimulation and multiple sclerosis: Therapeutic applications
|
Roy, Holly A. |
|
2014 |
|
4 |
p. 431-439 9 p. |
artikel |
18 |
Does natalizumab treatment increase the risk of herpes simplex encephalitis in multiple sclerosis? Case and discussion
|
Sharma, Kanchan |
|
2013 |
|
4 |
p. 385-387 3 p. |
artikel |
19 |
Editors’ Welcome
|
Banwell, Brenda |
|
2015 |
|
4 |
p. A1-A3 nvt p. |
artikel |
20 |
Editors' welcome
|
Banwell, Brenda |
|
2012 |
|
4 |
p. 153- 1 p. |
artikel |
21 |
Editors׳ welcome
|
Banwell, Brenda |
|
2014 |
|
4 |
p. 417-418 2 p. |
artikel |
22 |
Effectiveness of telerehabilitation interventions in persons with multiple sclerosis: A systematic review
|
Amatya, B. |
|
2015 |
|
4 |
p. 358-369 12 p. |
artikel |
23 |
Effects of dimethyl fumarate on lymphocyte subsets
|
Berkovich, Regina |
|
2015 |
|
4 |
p. 339-341 3 p. |
artikel |
24 |
Fatigue is associated with metabolic and density alterations of cortical and deep gray matter in Relapsing-Remitting-Multiple Sclerosis patients at the earlier stage of the disease: A PET/MR study
|
Derache, Nathalie |
|
2013 |
|
4 |
p. 362-369 8 p. |
artikel |
25 |
Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings
|
Kappos, Ludwig |
|
2014 |
|
4 |
p. 494-504 11 p. |
artikel |
26 |
Genetic and environmental backgrounds responsible for the changes in the phenotype of MS in Japanese subjects
|
Kira, Jun-ichi |
|
2012 |
|
4 |
p. 188-195 8 p. |
artikel |
27 |
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40mg three-times weekly versus 20mg daily in patients with relapsing-remitting multiple sclerosis
|
Wolinsky, Jerry S. |
|
2015 |
|
4 |
p. 370-376 7 p. |
artikel |
28 |
Health care utilization before and after intensive care unit admission in multiple sclerosis
|
Marrie, Ruth Ann |
|
2015 |
|
4 |
p. 296-303 8 p. |
artikel |
29 |
HLA DR and DQ alleles and haplotypes associated with clinical response to glatiramer acetate in multiple sclerosis
|
Dhib-Jalbut, Suhayl |
|
2013 |
|
4 |
p. 340-348 9 p. |
artikel |
30 |
Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis
|
Newsome, S.D. |
|
2015 |
|
4 |
p. 350-357 8 p. |
artikel |
31 |
Impaired recognition of emotional facial expressions in patients with multiple sclerosis
|
Berneiser, Julia |
|
2014 |
|
4 |
p. 482-488 7 p. |
artikel |
32 |
Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab
|
Rinker II, John R. |
|
2014 |
|
4 |
p. 505-512 8 p. |
artikel |
33 |
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
|
Giovannoni, Gavin |
|
2015 |
|
4 |
p. 329-333 5 p. |
artikel |
34 |
Late onset multiple sclerosis: Is it really late onset?
|
Roohani, Pezhman |
|
2014 |
|
4 |
p. 444-449 6 p. |
artikel |
35 |
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients
|
Sangalli, Francesca |
|
2014 |
|
4 |
p. 520-526 7 p. |
artikel |
36 |
Managing flushing and gastrointestinal events associated with delayed-release dimethyl fumarate: Experiences of an international panel
|
Phillips, J. Theodore |
|
2014 |
|
4 |
p. 513-519 7 p. |
artikel |
37 |
MRI characteristics of periaqueductal lesions in multiple sclerosis
|
Papadopoulou, Athina |
|
2014 |
|
4 |
p. 542-551 10 p. |
artikel |
38 |
Multiple Cranial Neuropathy (A Teaching Case)
|
Toro, Jaime |
|
2013 |
|
4 |
p. 395-398 4 p. |
artikel |
39 |
Muscular dystrophy in a patient with multiple sclerosis. Another “double-trouble”?
|
Parissis, Dimitrios |
|
2015 |
|
4 |
p. 342-344 3 p. |
artikel |
40 |
Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment
|
Barroso, Bruno |
|
2015 |
|
4 |
p. 380-382 3 p. |
artikel |
41 |
Neurologists׳ accuracy in predicting cognitive impairment in multiple sclerosis
|
Romero, Kristoffer |
|
2015 |
|
4 |
p. 291-295 5 p. |
artikel |
42 |
Neuroprotection for acute optic neuritis—Can it work?
|
Raftopoulos, R.E. |
|
2013 |
|
4 |
p. 307-311 5 p. |
artikel |
43 |
Nose to brain: Is the trigeminal nerve a conduit for CNS disease?
|
Gay, Frederick |
|
2012 |
|
4 |
p. 154-155 2 p. |
artikel |
44 |
Occupational stress and personality traits in multiple sclerosis: A preliminary study
|
Concetta Incerti, Chiara |
|
2015 |
|
4 |
p. 315-319 5 p. |
artikel |
45 |
Pathologic yawning in neuromyelitis optica spectrum disorders
|
Lana-Peixoto, Marco A. |
|
2014 |
|
4 |
p. 527-532 6 p. |
artikel |
46 |
Persistence of the effects of attention and executive functions intensive rehabilitation in relapsing remitting multiple sclerosis
|
Mattioli, F. |
|
2012 |
|
4 |
p. 168-173 6 p. |
artikel |
47 |
Potential therapeutic mechanism of K+ channel block for MS
|
Baker, Mark D. |
|
2013 |
|
4 |
p. 270-280 11 p. |
artikel |
48 |
Presentation of neuromyelitis optica spectrum disorder after more than twenty years of systemic sclerosis
|
Hernández, Zulma M. |
|
2012 |
|
4 |
p. 202-203 2 p. |
artikel |
49 |
Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study
|
Marrie, Ruth Ann |
|
2013 |
|
4 |
p. 355-361 7 p. |
artikel |
50 |
Progressive multifocal leukoencephalopathy and JC Virus-related disease in modern neurology practice
|
Carruthers, Robert L. |
|
2014 |
|
4 |
p. 419-430 12 p. |
artikel |
51 |
Promoting regeneration and repair in Multiple Sclerosis
|
Banwell, B. |
|
2013 |
|
4 |
p. 261-262 2 p. |
artikel |
52 |
Promoting return of function in multiple sclerosis: An integrated approach
|
Gacias, Mar |
|
2013 |
|
4 |
p. 312-326 15 p. |
artikel |
53 |
Relation of quantitative visual and neurologic outcomes to fatigue in multiple sclerosis
|
Chahin, Salim |
|
2015 |
|
4 |
p. 304-310 7 p. |
artikel |
54 |
Review of animal models of neuromyelitis optica
|
Jones, Melina V. |
|
2012 |
|
4 |
p. 174-179 6 p. |
artikel |
55 |
Sodium imaging as a marker of tissue injury in patients with multiple sclerosis
|
Inglese, M. |
|
2013 |
|
4 |
p. 263-269 7 p. |
artikel |
56 |
Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: A meta-analysis
|
Ruiz-Gaviria, Rafael |
|
2015 |
|
4 |
p. 345-349 5 p. |
artikel |
57 |
The case for vitamin D supplementation in multiple sclerosis
|
Ganesh, Aravind |
|
2013 |
|
4 |
p. 281-306 26 p. |
artikel |
58 |
The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk
|
Khatri, Bhupendra O. |
|
2015 |
|
4 |
p. 377-379 3 p. |
artikel |
59 |
The effect of menarche age, parity and lactation on bone mineral density in premenopausal ambulatory multiple sclerosis patients
|
Sioka, Chrissa |
|
2015 |
|
4 |
p. 287-290 4 p. |
artikel |
60 |
The incidence and prevalence of fibromyalgia are higher in multiple sclerosis than the general population: A population-based study
|
Marrie, Ruth Ann |
|
2012 |
|
4 |
p. 162-167 6 p. |
artikel |
61 |
The UK patient experience of relapse in Multiple Sclerosis treated with first disease modifying therapies
|
Duddy, Martin |
|
2014 |
|
4 |
p. 450-456 7 p. |
artikel |
62 |
Treatment of neuromyelitis optica: Review and recommendations
|
Kimbrough, Dorlan J. |
|
2012 |
|
4 |
p. 180-187 8 p. |
artikel |
63 |
Varicella vaccination after fingolimod: A case report
|
Berger, Joseph R. |
|
2013 |
|
4 |
p. 391-394 4 p. |
artikel |
64 |
Walking for six minutes increases both simple reaction time and stepping reaction time in moderately disabled people with Multiple Sclerosis
|
Barr, Christopher |
|
2014 |
|
4 |
p. 457-462 6 p. |
artikel |
65 |
Web search behavior for multiple sclerosis: An infodemiological study
|
Brigo, Francesco |
|
2014 |
|
4 |
p. 440-443 4 p. |
artikel |
66 |
White matter relapsing remitting disease: “Susac’s syndrome”—An underdiagnosed entity
|
Schottlaender, Lucia V. |
|
2013 |
|
4 |
p. 349-354 6 p. |
artikel |
67 |
Why some of us do not like the expression “no evidence of disease activity” (NEDA) in multiple sclerosis
|
Dadalti Fragoso, Yara |
|
2015 |
|
4 |
p. 383-384 2 p. |
artikel |